Recently, Quezada and his colleagues reported that inhibition of CD73 activity or knocking down CD73 expression by siRNA reversed the vincristine resistance phenotype of glioblastoma multiforme (GBM) cells [8]. This evidence concerns the gene NT5E and glioblastoma.